Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

B&L updates guidance

This article was originally published in The Tan Sheet

Executive Summary

Bausch & Lomb recall of MoistureLoc contact solution leads to an 8-K filing with the SEC to update information on its outstanding bank and public debt, Rochester, N.Y.-based firm announces Jan. 31. B&L also provides an updated financial forecast concerning its expectations for 2006 and 2007 sales and income. The firm currently expects sales of approximately $2.3 bil. reflecting "slower than anticipated rate of recovery" in Asia due to the recall. The firm also predicts full-year 2006 income before income taxes and minority interest as approximately $74 mil...

You may also be interested in...



Another ReNu Recall Begins While 2006 Episode Clouds B&L Earnings

Bausch & Lomb announced a voluntary recall of its ReNu MultiPlus contact lens solution the same day it reported the May 2006 worldwide recall of ReNu with MoistureLoc "led to declines in consolidated gross margins" for the full year

HBW Product Launches: VitaFusion Goodness, Colgate Zero, Tom’s Prebiotic, Gaia Hemp & Herb

Colgate Zero toothpastes and mouthwashes promote what’s missing; Tom’s of Maine natural personal care expands with prebiotic toothpaste, deodorant and hand soap; Gaia adds hemp to its herbs; and Church & Dwight goes environmentally friendly with VitaFusion Goodness supplements, adds CBD versions to line, too.

High-Priced Entries Drive 17% Rise In Spending On Anti-Inflammatory Drugs

But declines in other categories held overall spending on US retail pharmacy drugs covered by commercial plans to a marginal 2.3% increase in 2019, Express Scripts reports.

Topics

UsernamePublicRestriction

Register

PS100175

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel